Immuneel Therapeutics, a cancer therapy startup cofounded by Biocon founder Kiran Mazumdar-Shaw, has raised over Rs 100 crore in new funding to expand manufacturing, reduce treatment costs and take its therapy to markets outside India.
The round saw participation from Singularity AMC, Rainmatter by Zerodha, high-net-worth individuals, and existing investors, including Mazumdar-Shaw, Eight Roads Ventures and F-Prime Capital, the company said in a statement on Monday.
